Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915922 · ClinicalTrials.gov registry record · NA
YAG Laser Vitreolysis for Vitreous Floaters
A NA study of Posterior Vitreous Detachment and Myopic Vitreopathy, sponsored by VMR Consulting.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06915922 is a NA study of Posterior Vitreous Detachment and Myopic Vitreopathy that is actively recruiting participants, run by VMR Consulting. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06915922, a NA study of Posterior Vitreous Detachment and Myopic Vitreopathy, is actively recruiting participants, sponsored by VMR Consulting.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser. The FDA has approved the use of this laser to treat membranes in the eye.
Conditions Studied
Interventions
- DEVICE Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser therapy
Study Locations (1)
California
- VMR Institute for Vitreous Macula Retina - Huntington Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-10-17 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06915922
The ClinicalTrials.gov registry entry for NCT06915922 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VMR Consulting, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Posterior Vitreous Detachment appearing as the primary indexed condition, and to 1 intervention - of which Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser therapy is the first listed.
NCT06915922 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06915922 about?
NCT06915922 is a clinical study titled "YAG Laser Vitreolysis for Vitreous Floaters". The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated u...
What is the current status of trial NCT06915922?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-10-17. Estimated completion is 2026-05.
What conditions does trial NCT06915922 study?
This clinical trial studies the following conditions: Posterior Vitreous Detachment, Myopic Vitreopathy, Vision Degrading Myodesopsia.
What interventions are being tested in trial NCT06915922?
The interventions under investigation include: Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser therapy (DEVICE).
Who is sponsoring clinical trial NCT06915922?
This trial is sponsored by VMR Consulting, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06915922 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posterior Vitreous Detachment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.